Switch theme
Sign up to access all valuation multiples
Beijing Balance Medical Technology Co Ltd is engaged in the research and development and production of animal-derived implantable medical devices. The company's products are used in heart valve replacement and repair, congenital heart disease implant intervention and surgical soft tissue repair.
2005
n/a
Last FY Revenue $69.7M
Last FY EBITDA $24.2M
$2.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Beijing Balance Medical achieved revenue of $69.7M and an EBITDA of $24.2M.
Beijing Balance Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Beijing Balance Medical valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $69.7M | XXX | XXX | XXX |
| Gross Profit | XXX | $61.5M | XXX | XXX | XXX |
| Gross Margin | XXX | 88% | XXX | XXX | XXX |
| EBITDA | XXX | $24.2M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 35% | XXX | XXX | XXX |
| EBIT | XXX | $19.2M | XXX | XXX | XXX |
| EBIT Margin | XXX | 28% | XXX | XXX | XXX |
| Net Profit | XXX | $20.3M | XXX | XXX | XXX |
| Net Margin | XXX | 29% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Beijing Balance Medical's stock price is CNY 110 (or $15).
Beijing Balance Medical has current market cap of CNY 15.1B (or $2.1B), and EV of CNY 14.9B (or $2.1B).
See Beijing Balance Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.1B | $2.1B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Beijing Balance Medical has market cap of $2.1B and EV of $2.1B.
Beijing Balance Medical's trades at 29.6x EV/Revenue multiple, and 85.3x EV/EBITDA.
Equity research analysts estimate Beijing Balance Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Beijing Balance Medical's P/E ratio is not available.
See valuation multiples for Beijing Balance Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.1B | XXX | $2.1B | XXX | XXX | XXX |
| EV (current) | $2.1B | XXX | $2.1B | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 29.6x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 85.3x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 107.7x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 103.0x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -550.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBeijing Balance Medical's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Beijing Balance Medical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Beijing Balance Medical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Beijing Balance Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 35% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 15% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 30% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 61% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Beijing Balance Medical acquired XXX companies to date.
Last acquisition by Beijing Balance Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Beijing Balance Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Beijing Balance Medical founded? | Beijing Balance Medical was founded in 2005. |
| Where is Beijing Balance Medical headquartered? | Beijing Balance Medical is headquartered in China. |
| Is Beijing Balance Medical publicy listed? | Yes, Beijing Balance Medical is a public company listed on SHG. |
| What is the stock symbol of Beijing Balance Medical? | Beijing Balance Medical trades under 688198 ticker. |
| When did Beijing Balance Medical go public? | Beijing Balance Medical went public in 2019. |
| Who are competitors of Beijing Balance Medical? | Similar companies to Beijing Balance Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Beijing Balance Medical? | Beijing Balance Medical's current market cap is $2.1B |
| Is Beijing Balance Medical profitable? | Yes, Beijing Balance Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
